Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
HKBU Chinese Herbal Medicine Formula for COVID-19
- Development stage
- Unknown
- Lead developer
- School of Chinese Medicine, Hong Kong Baptist University
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
HKBU Chinese Herbal Medicine Formula for COVID-19 is a specific 10-herb granule formulation developed by Hong Kong Baptist University (HKBU) for the prevention and treatment of SARS-CoV-2 infection. The formula is comprised of ten traditional medicinal herbs: *Codonopsis Radix*, *Astragali Radix*, *Lonicerae Japonicae Flos*, *Saposhnikovia Radix*, *Schizonepetae Herba*, *Mori Folium*, *Poria*, *Atractylodis Rhizoma*, *Atractylodis Macrocephala Rhizoma*, and *Glycyrrhizae Radix et Rhizoma*. It is designed to enhance host immune function and provide potential antiviral activity. Clinical research conducted by HKBU has evaluated the efficacy and safety of these granules in preventing COVID-19 transmission among high-risk populations, including healthcare workers (often in combination with Vitamin C) and close contacts of infected individuals.
- Other names
- Chinese herbal medicine-Hong Kong Baptist University-COVID-19HKBU 10-herb formulaHKBU10-herb formulaHKBU-10-herb formula
02
Targets
ACE2 (Angiotensin-converting enzyme 2)Mpro (3C-like proteinase of SARS-CoV-2)ADRA1A (α1A)ESR1 (ERα)HDAC1 (Histone Deacetylase 1)ACE (Angiotensin Converting Enzyme)
Beyond the preview
Go deeper on HKBU Chinese Herbal Medicine Formula for COVID-19.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HKBU Chinese Herbal Medicine Formula for COVID-19.